CN112168726A - 一种皮肤调理膏及方法 - Google Patents
一种皮肤调理膏及方法 Download PDFInfo
- Publication number
- CN112168726A CN112168726A CN202011051207.3A CN202011051207A CN112168726A CN 112168726 A CN112168726 A CN 112168726A CN 202011051207 A CN202011051207 A CN 202011051207A CN 112168726 A CN112168726 A CN 112168726A
- Authority
- CN
- China
- Prior art keywords
- oil
- skin
- component
- leaf
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000003750 conditioning effect Effects 0.000 title claims abstract description 27
- 239000006071 cream Substances 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 19
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 claims abstract description 36
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 35
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000000294 eucalyptus globulus labille leaf/twig oil Substances 0.000 claims abstract description 22
- 229940119170 jojoba wax Drugs 0.000 claims abstract description 22
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 claims abstract description 22
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 claims abstract description 21
- 239000010627 cedar oil Substances 0.000 claims abstract description 21
- 239000001198 melaleuca alternifolia leaf oil Substances 0.000 claims abstract description 21
- 239000010668 rosemary oil Substances 0.000 claims abstract description 21
- 229940058206 rosemary oil Drugs 0.000 claims abstract description 21
- 239000010678 thyme oil Substances 0.000 claims abstract description 21
- 239000001098 melissa officinalis l. leaf oil Substances 0.000 claims abstract description 20
- 229940081859 myrrh extract Drugs 0.000 claims abstract description 20
- 239000010661 oregano oil Substances 0.000 claims abstract description 20
- 229940111617 oregano oil Drugs 0.000 claims abstract description 20
- 229930003799 tocopherol Natural products 0.000 claims abstract description 19
- 239000011732 tocopherol Substances 0.000 claims abstract description 19
- 229960001295 tocopherol Drugs 0.000 claims abstract description 19
- 235000010384 tocopherol Nutrition 0.000 claims abstract description 19
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims abstract description 19
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims abstract description 18
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 claims abstract description 18
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 claims abstract description 18
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 claims abstract description 18
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 claims abstract description 18
- 229940075529 glyceryl stearate Drugs 0.000 claims abstract description 15
- 229940105040 geranium extract Drugs 0.000 claims abstract description 14
- 241000196324 Embryophyta Species 0.000 claims abstract description 12
- 239000000126 substance Substances 0.000 claims abstract description 11
- 238000001816 cooling Methods 0.000 claims abstract description 10
- 238000003756 stirring Methods 0.000 claims abstract description 8
- 238000010438 heat treatment Methods 0.000 claims abstract description 7
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 239000000341 volatile oil Substances 0.000 claims description 27
- 239000002994 raw material Substances 0.000 claims description 11
- 244000270673 Pelargonium graveolens Species 0.000 claims description 9
- 235000017927 Pelargonium graveolens Nutrition 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 238000005303 weighing Methods 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 8
- 239000000463 material Substances 0.000 claims description 7
- 238000007667 floating Methods 0.000 claims description 6
- 244000178870 Lavandula angustifolia Species 0.000 claims description 5
- 235000010663 Lavandula angustifolia Nutrition 0.000 claims description 5
- 244000166124 Eucalyptus globulus Species 0.000 claims description 4
- 244000062730 Melissa officinalis Species 0.000 claims description 4
- 235000007265 Myrrhis odorata Nutrition 0.000 claims description 4
- 235000007303 Thymus vulgaris Nutrition 0.000 claims description 4
- 239000001102 lavandula vera Substances 0.000 claims description 4
- 235000018219 lavender Nutrition 0.000 claims description 4
- 238000002156 mixing Methods 0.000 claims description 4
- 239000001585 thymus vulgaris Substances 0.000 claims description 4
- 241000218645 Cedrus Species 0.000 claims description 3
- 235000006965 Commiphora myrrha Nutrition 0.000 claims description 3
- 235000004692 Eucalyptus globulus Nutrition 0.000 claims description 3
- 241000366182 Melaleuca alternifolia Species 0.000 claims description 3
- 238000009833 condensation Methods 0.000 claims description 3
- 230000005494 condensation Effects 0.000 claims description 3
- 238000004821 distillation Methods 0.000 claims description 3
- 238000001704 evaporation Methods 0.000 claims description 3
- 238000000605 extraction Methods 0.000 claims description 3
- 238000007710 freezing Methods 0.000 claims description 3
- 230000008014 freezing Effects 0.000 claims description 3
- 239000001366 lippia graveolens leaf Substances 0.000 claims description 3
- 238000002844 melting Methods 0.000 claims description 3
- 230000008018 melting Effects 0.000 claims description 3
- 239000001331 rosmarinus officinalis leaf Substances 0.000 claims description 3
- 240000007311 Commiphora myrrha Species 0.000 claims 1
- 240000002657 Thymus vulgaris Species 0.000 claims 1
- 239000002884 skin cream Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 29
- 208000003251 Pruritus Diseases 0.000 abstract description 7
- 230000008439 repair process Effects 0.000 abstract description 4
- 238000004140 cleaning Methods 0.000 abstract description 3
- 230000005808 skin problem Effects 0.000 abstract description 3
- 230000001954 sterilising effect Effects 0.000 abstract description 3
- 230000007803 itching Effects 0.000 abstract description 2
- 210000004243 sweat Anatomy 0.000 abstract description 2
- -1 myrrh extract Substances 0.000 abstract 2
- 206010020751 Hypersensitivity Diseases 0.000 abstract 1
- 208000026935 allergic disease Diseases 0.000 abstract 1
- 230000007815 allergy Effects 0.000 abstract 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 abstract 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 59
- 239000000047 product Substances 0.000 description 38
- 210000002683 foot Anatomy 0.000 description 28
- 208000024891 symptom Diseases 0.000 description 22
- 239000000203 mixture Substances 0.000 description 12
- 241000894006 Bacteria Species 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 6
- 208000002894 beriberi Diseases 0.000 description 6
- 208000025865 Ulcer Diseases 0.000 description 5
- 206010052428 Wound Diseases 0.000 description 5
- 208000027418 Wounds and injury Diseases 0.000 description 5
- 230000000172 allergic effect Effects 0.000 description 5
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 208000010668 atopic eczema Diseases 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 238000009472 formulation Methods 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- 238000002560 therapeutic procedure Methods 0.000 description 5
- 206010015150 Erythema Diseases 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 231100000321 erythema Toxicity 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 230000008929 regeneration Effects 0.000 description 4
- 238000011069 regeneration method Methods 0.000 description 4
- 231100000241 scar Toxicity 0.000 description 4
- 230000036269 ulceration Effects 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 241000208152 Geranium Species 0.000 description 3
- 240000009023 Myrrhis odorata Species 0.000 description 3
- 241000246358 Thymus Species 0.000 description 3
- 208000002474 Tinea Diseases 0.000 description 3
- 241000130764 Tinea Species 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 230000001580 bacterial effect Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 230000002708 enhancing effect Effects 0.000 description 3
- 210000003780 hair follicle Anatomy 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 239000011148 porous material Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 238000002791 soaking Methods 0.000 description 3
- 239000013589 supplement Substances 0.000 description 3
- 208000032544 Cicatrix Diseases 0.000 description 2
- DZNVIZQPWLDQHI-UHFFFAOYSA-N Citronellyl formate Chemical compound O=COCCC(C)CCC=C(C)C DZNVIZQPWLDQHI-UHFFFAOYSA-N 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- 208000033809 Suppuration Diseases 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- WUOACPNHFRMFPN-UHFFFAOYSA-N alpha-terpineol Chemical compound CC1=CCC(C(C)(C)O)CC1 WUOACPNHFRMFPN-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 230000007123 defense Effects 0.000 description 2
- SQIFACVGCPWBQZ-UHFFFAOYSA-N delta-terpineol Natural products CC(C)(O)C1CCC(=C)CC1 SQIFACVGCPWBQZ-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000001804 emulsifying effect Effects 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 239000004519 grease Substances 0.000 description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000012466 permeate Substances 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 210000004927 skin cell Anatomy 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 230000035882 stress Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 239000010677 tea tree oil Substances 0.000 description 2
- 229940111630 tea tree oil Drugs 0.000 description 2
- 229940116411 terpineol Drugs 0.000 description 2
- 201000004647 tinea pedis Diseases 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- NFLGAXVYCFJBMK-RKDXNWHRSA-N (+)-isomenthone Natural products CC(C)[C@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-RKDXNWHRSA-N 0.000 description 1
- FAMJUFMHYAFYNU-JTQLQIEISA-N (4r)-1-methyl-4-propan-2-ylcyclohexene Chemical compound CC(C)[C@@H]1CCC(C)=CC1 FAMJUFMHYAFYNU-JTQLQIEISA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- WEEGYLXZBRQIMU-UHFFFAOYSA-N 1,8-cineole Natural products C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 1
- LQIAZOCLNBBZQK-UHFFFAOYSA-N 1-(1,2-Diphosphanylethyl)pyrrolidin-2-one Chemical compound PCC(P)N1CCCC1=O LQIAZOCLNBBZQK-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 235000009024 Ceanothus sanguineus Nutrition 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- WEEGYLXZBRQIMU-WAAGHKOSSA-N Eucalyptol Chemical compound C1C[C@H]2CC[C@]1(C)OC2(C)C WEEGYLXZBRQIMU-WAAGHKOSSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 240000003553 Leptospermum scoparium Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- NFLGAXVYCFJBMK-UHFFFAOYSA-N Menthone Chemical compound CC(C)C1CCC(C)CC1=O NFLGAXVYCFJBMK-UHFFFAOYSA-N 0.000 description 1
- 241001057584 Myrrha Species 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 241001529744 Origanum Species 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000004277 Pelargonium radens Species 0.000 description 1
- 235000012550 Pimpinella anisum Nutrition 0.000 description 1
- 206010039509 Scab Diseases 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 206010040849 Skin fissures Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010046914 Vaginal infection Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 208000000260 Warts Diseases 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000007177 brain activity Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 230000001595 contractor effect Effects 0.000 description 1
- 201000010251 cutis laxa Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- ZHYZQXUYZJNEHD-VQHVLOKHSA-N geranic acid Chemical compound CC(C)=CCC\C(C)=C\C(O)=O ZHYZQXUYZJNEHD-VQHVLOKHSA-N 0.000 description 1
- 229930008392 geranic acid Natural products 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 239000010648 geranium oil Substances 0.000 description 1
- 235000019717 geranium oil Nutrition 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000037315 hyperhidrosis Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 235000001510 limonene Nutrition 0.000 description 1
- 229940087305 limonene Drugs 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 229930007503 menthone Natural products 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000037312 oily skin Effects 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 238000011056 performance test Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002633 protecting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000006748 scratching Methods 0.000 description 1
- 230000002393 scratching effect Effects 0.000 description 1
- 210000002374 sebum Anatomy 0.000 description 1
- 230000009758 senescence Effects 0.000 description 1
- 230000037307 sensitive skin Effects 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 201000010153 skin papilloma Diseases 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000002344 surface layer Substances 0.000 description 1
- 229930006978 terpinene Natural products 0.000 description 1
- 150000003507 terpinene derivatives Chemical class 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- ZHYZQXUYZJNEHD-UHFFFAOYSA-N trans-geranic acid Natural products CC(C)=CCCC(C)=CC(O)=O ZHYZQXUYZJNEHD-UHFFFAOYSA-N 0.000 description 1
- 230000032258 transport Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
- A61K8/375—Esters of carboxylic acids the alcohol moiety containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/342—Alcohols having more than seven atoms in an unbroken chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/463—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfuric acid derivatives, e.g. sodium lauryl sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/678—Tocopherol, i.e. vitamin E
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Cosmetics (AREA)
Abstract
本发明公开了一种皮肤调理膏及方法,一种皮肤调理膏,由以下各物质制成:水、甘油硬脂酸酯、没药提取物、互叶白千层叶油、薰衣草油、十八醇克、香叶天竺葵提取物、蓝桉叶油、迷迭香油、生育酚、氢化霍霍巴油、牛至油、百里香油、雪柏油、香蜂草油、十二烷基硫酸钠、羟苯乙酯。一种皮肤调理膏的方法,制备方法包括以下步骤:将第一组分和第二组分分别加热至80摄氏度,然后将第二组分加入至第一组分中,不断搅拌,在冷却至30摄氏度时加入第三组分,充分搅拌,完成制备。本发明主要以纯天然植物成分为配方,深入修护足部皮肤问题,不掉皮,不过敏,安全无副作用,具有杀菌止痒、清洁肌肤、去除足汗、去除异味的功效。
Description
技术领域
本发明涉及一种调理膏及方法,尤其涉及一种皮肤(尤其是足部皮肤修护)调理膏及方法,属于化妆品技术领域。
背景技术
随着人们生活水平提高,人们对足部养生的理念越来越认同,足疗也已经成为我们的一种生活方式,其消费人群非常的广泛,不管是男女老少还是经营白领,都开始接触到足疗,随着足疗消费人群的增多,市场的发展空间巨大,足疗的方式和产品也越来越多。但是现阶段,市场上足疗的产品绝大部分都是概念性的产品,真正对足部问题有功效的产品很少。有立竿见影功效的产品又绝大部分都是化工产品,相对来讲,这些产品副作用较大。
现阶段人们对足疗产品的成分要求越来越高,开发集营养性、功能性、天然性于一体的护肤、足疗产品将具有重要的应用前景。营养性是指皮肤吸收后可促进皮肤的新陈代谢、延缓皮肤衰老;功能性是指应具有良好的护肤功能,无不良反应,使用效果好;天然性是指原料中应有绿色、无毒、无害的天然产品或人工种植产品。鉴于现有的足疗产品中对上述原材料及性能的要求均符合程度不高,因此亟需开发一种新型的护肤组合物配方,以满足人们的使用需求。
发明内容
为了解决上述技术所存在的不足之处,本发明提供了一种皮肤调理膏及方法。
为了解决以上技术问题,本发明采用的技术方案是:一种皮肤调理膏,由以下质量份的各物质制成:
水20-50克、甘油硬脂酸酯10-30克、没药提取物3-10克、互叶白千层叶油2-10克、薰衣草油2-10克、十八醇5-7克、香叶天竺葵提取物1-6克、蓝桉叶油2-5克、迷迭香油2-5克、生育酚1-3克、氢化霍霍巴油1-3克、牛至油1-3克、百里香油1-3克、雪柏油1-3克、香蜂草油1-3克、十二烷基硫酸钠1克、羟苯乙酯0.05-0.2克。
进一步地,调理膏由以下质量份的各物质制成:
水20克、甘油硬脂酸酯10克、没药提取物3克、互叶白千层叶油2克、薰衣草油2克、十八醇5克、香叶天竺葵提取物1克、蓝桉叶油2克、迷迭香油2克、生育酚1克、氢化霍霍巴油1克、牛至油1克、百里香油1克、雪柏油1克、香蜂草油1克、十二烷基硫酸钠1克、羟苯乙酯0.05克。
进一步地,调理膏由以下质量份的各物质制成:
水50克、甘油硬脂酸酯30克、没药提取物10克、互叶白千层叶油10克、薰衣草油10克、十八醇7克、香叶天竺葵提取物6克、蓝桉叶油5克、迷迭香油5克、生育酚3克、氢化霍霍巴油3克、牛至油3克、百里香油3克、雪柏油3克、香蜂草油3克、十二烷基硫酸钠1克、羟苯乙酯0.2克。
一种皮肤调理膏的方法,制备方法包括以下步骤:
分别称取甘油硬脂酸酯10-30克、没药提取物3-10克、互叶白千层叶油2-10克、薰衣草油2-10克、十八醇5-7克、蓝桉叶油2-5克、迷迭香油2-5克、生育酚1-3克、氢化霍霍巴油1-3克,形成第一组分;
分别称取水20-50克、十二烷基硫酸钠1克、羟苯乙酯0.05-0.2克混合均匀,形成第二组分;
称取香叶天竺葵提取物1-6克,牛至油1-3克,百里香油1-3克,雪柏油1-3克,香蜂草油1-3克,形成第三组分;
将第一组分和第二组分分别加热至80摄氏度,然后将第二组分加入至第一组分中,不断搅拌,在冷却至30摄氏度时加入第三组分,充分搅拌,完成制备;制备好的成品在分装之前需要放置于干燥、阴凉不见光环境。
进一步地,没药提取物、互叶白千层叶油、薰衣草油、香叶天竺葵提取物、蓝桉叶油、迷迭香油、牛至油、百里香油、雪柏油、香蜂草油是分别以新鲜或干燥的没药、互叶白千层叶、薰衣草、香叶天竺葵、蓝桉叶、迷迭香花叶、牛至叶、百里香花叶、雪柏枝叶、香蜂草枝叶为原料,然后分别经以下工序制作而成:
粉碎:将各成分新鲜的或经过干燥的植物材料分别进行粉碎处理;
蒸馏:将经粉粹处理的材料分别放进蒸气热熔炉中,由下方加热送入蒸气,把植物中的挥发性精油蒸发出来,使之变成含有精油的水蒸气状态;
冷凝:再通过急冻箱的导管收集冷却后,水蒸气因冷却而凝结成液态,冷凝后精油浮于液面;
提取:再比较水与精油的密度将浮于液面的精油分离出来,得到调配皮肤修护精华油的各种成品原料。
在本发明的主要组分中:
水可最大限度的溶解各成分,从而更有利于各营养成分被皮肤所吸收。甘油硬脂酸酯是一种基于植物原料来源的温和的非离子表面活性剂和增溶剂、乳化剂,具有良好的乳化性能。十八醇用于高级化妆品中膏霜、乳液的基本原料,具有乳化、增稠、保湿、润滑功效。十二烷基硫酸钠用于高级化妆品中膏霜、乳液的基本原料,是一种乳化稳定剂。羟苯乙酯防腐剂是医药级的广谱高效防腐剂。
生育酚又名维生素E,是目前大量生产的天然油溶性抗氧化剂,可以有效阻止脂肪氧化时活性氧化物的形成,从而增加细胞的抗氧化作用,延缓衰老,还可以改善脂质代谢、防止动脉硬化、降低血脂等,因此,使用生育酚作为抗氧剂应用在美容产品中不会对人体健康造成任何危害,具有天然无污染、无副作用的优点。
没药提取物可杀菌,消毒力强,可以抑制皮肤炎症,能滋润干裂和冻疮皮肤,对皱纹也有效。而且气味可让人感到温暖宜人,增强脑部活力,恢复身心朝气,清醒头脑。
互叶白千层叶油也叫茶树油,为茶树的提取物,最主要的化学成分为对孟乙烯、松油精、柠檬油精、桉油酚、香油脑、茴香素。茶树油是一种天然的消毒剂,对于治疗许多疾病、创伤有很大帮助,如切伤、擦伤、被昆虫咬伤、粉刺、烧伤、阴道感染、癣等;净化效果绝佳,改善伤口感染的化脓现象,以及疖,可应用于灼伤、疮、晒伤、癣、疣、圆癣、疱疹和香港脚;具有杀菌消炎、收敛毛孔等功效,适用于油性及粉刺皮肤,治疗化脓伤口及灼伤、晒伤、香港脚及头屑;能使头脑清醒,恢复活力,抗沮丧。
薰衣草油有止痛、抗忧郁、消毒、杀菌和解除充血与肿胀的功用,还有降血压、驱虫、镇定和回复健康的效果。它能舒缓修护过敏性肤质,缓解因压力、精神紧张和情绪低落引起的皮肤天然抵抗能力减弱,恢复皮肤自我修护机能,强化肌肤对外界的抵抗力。薰衣草油搭配多种纯植物精油活性因子相辅相成,能快速渗透毛囊消毒抗菌,促进细胞再生,促进小伤口迅速愈合,恢复皮肤结缔组织,预防疤痕痘印遗留,调理肌肤到水油平衡的最佳状态。薰衣草油有超强的渗透能力,能迅速进入皮肤下240微米的细菌根除,彻底清除因皮肤下细菌滋生、毛囊堵塞所引起的皮肤问题,在肌肤真皮层形成黄金保护膜,抵御细菌再次滋生。薰衣草搭配多种纯植物精油活性因子相辅相成,能快速渗透毛囊消毒抗菌,促进细胞再生,恢复皮肤结缔组织,同时平衡肌肤表层油脂分泌、舒缓敏感肌肤、收敛毛孔、补充肌肤水分,持久保护肌肤不受细菌干扰,恢复细腻光滑肌肤。
香叶天竺葵油能止痛、收敛抗菌、伸进织疤、增强细胞防御功能,其能深层洁肤,平衡皮脂分泌,促进皮肤细胞新生,修复疤痕。天竺葵精油中含有香茅醇、甲酸香茅酯、松烯、牛儿酸、牻牛儿醇、松油醇、柠檬醛、薄荷酮和多种微量矿物元素,其主要功能在于调肤,天竺葵提取液中的有效成分与天然有机脂具有很强的亲和性。天竺葵油几乎适合各种皮肤状况,具有止痛、抗菌、伸进织疤、增强细胞防御功能、除臭、止血、补身等功效;在泡脚的热水中滴入几滴天竺葵精油,可以达到活血经络的目的,还能达到去除脚气脚臭的效果。
蓝桉叶油也叫尤加利油,对皮肤烫伤有明显功效,预防细菌滋生和蓄脓,促进新组织的建构;割伤、伤口、溃疡与发炎症状,使用尤加利油后均反应良好。在泡脚的热水中滴入几滴尤加利精油,可以达到活血经络的目的,还能达到去除脚气脚臭的效果。
氢化霍霍巴油就是将霍霍巴油催化加氢,使之呈固体或半固体状态,便于运输和使用,但是其功效是不会减少的,仍旧含有丰富的维生素A、B、E和钙、镁等矿物质,具有强抗氧化性,且与其他油类相比更加不易变质,极其不易滋生细菌具有抗菌性,经过多次试验证明,霍霍芭油对肌肤有十分显著的美容功效,可畅通毛细孔,调节油性或混合性肌肤的油脂分泌,并改善发炎的皮肤,对过敏性皮肤有一定的疗效与舒缓功效。
迷迭香油有很强的收缩作用,紧缩松弛的肌肤,还可减轻充血、肿胀的情形。牛至油具有很强的杀菌抑菌及抗氧化作用。
百里香油是最强的抗菌剂之一。在泡脚的热水中滴入几滴百里香精油,可以达到活血经络的目的,还能达到去除脚气脚臭的效果。还能促进血液循环,增强免疫力
血柏油能保持体液平衡,控制水分流失,对多汗及油性肌肤会有调节作用。还能促进结疤的功能,有利于伤口的愈合。香蜂草油可以调理易过敏的肤质,让新陈代谢正常,使肌肤有健康的光泽。
以上各种天然植物材料按合理配方,经过特定的调配方法,充分融合,相互作用,对皮肤(尤其是足部皮肤)修护功效显著。除了能帮助解决足部皮肤常见问题,还能促进皮肤细胞再生,使皮肤恢复健康、润泽,效果明显。
本发明主要以纯天然植物成分为配方,集营养性、功能性、天然性于一体,深入修护足部皮肤问题,不掉皮,不过敏,安全无副作用,具有杀菌止痒、清洁肌肤、去除足汗、去除异味的功效;能够软化角质、防止干裂、促进血液循环、滋润粗糙肌肤、修复肌肤,使肌肤细腻柔滑,保持皮肤莹润有光泽,增强人体气色,以上配方产品自带天然芬芳气息,使用过程中,还能通过气味从身心同时调理,能让使用者获得更高的享受。
具体实施方式
下面结合具体实施方式对本发明作进一步详细的说明。
一种皮肤调理膏,由以下质量份的各物质制成:
水20-50克、甘油硬脂酸酯10-30克、没药提取物3-10克、互叶白千层叶油2-10克、薰衣草油2-10克、十八醇5-7克、香叶天竺葵提取物1-6克、蓝桉叶油2-5克、迷迭香油2-5克、生育酚1-3克、氢化霍霍巴油1-3克、牛至油1-3克、百里香油1-3克、雪柏油1-3克、香蜂草油1-3克、十二烷基硫酸钠1克、羟苯乙酯0.05-0.2克。
一种皮肤调理膏的方法,制备方法包括以下步骤:
分别称取甘油硬脂酸酯10-30克、没药提取物3-10克、互叶白千层叶油2-10克、薰衣草油2-10克、十八醇5-7克、蓝桉叶油2-5克、迷迭香油2-5克、生育酚1-3克、氢化霍霍巴油1-3克,形成第一组分;
分别称取水20-50克、十二烷基硫酸钠1克、羟苯乙酯0.05-0.2克混合均匀,形成第二组分;
称取香叶天竺葵提取物1-6克,牛至油1-3克,百里香油1-3克,雪柏油1-3克,香蜂草油1-3克,形成第三组分;
将第一组分和第二组分分别加热至80摄氏度,然后将第二组分加入至第一组分中,不断搅拌,在冷却至30摄氏度时加入第三组分,充分搅拌,完成制备;制备好的成品在分装之前需要放置于干燥、阴凉不见光环境。
没药提取物、互叶白千层叶油、薰衣草油、香叶天竺葵提取物、蓝桉叶油、迷迭香油、牛至油、百里香油、雪柏油、香蜂草油是分别以新鲜或干燥的没药、互叶白千层叶、薰衣草、香叶天竺葵、蓝桉叶、迷迭香花叶、牛至叶、百里香花叶、雪柏枝叶、香蜂草枝叶为原料,然后分别经以下工序制作而成:
粉碎:将各成分新鲜的或经过干燥的植物材料分别进行粉碎处理;
蒸馏:将经粉粹处理的材料分别放进蒸气热熔炉中,由下方加热送入蒸气,把植物中的挥发性精油蒸发出来,使之变成含有精油的水蒸气状态;
冷凝:再通过急冻箱的导管收集冷却后,水蒸气因冷却而凝结成液态,冷凝后精油浮于液面;
提取:再比较水与精油的密度将浮于液面的精油分离出来,得到调配皮肤修护精华油的各种成品原料。
为了进一步支持本发明的配方成分,下面通过具体实施例对本发明作进一步详细的说明。
实施例1、
本实施例包括如下组成的各物质:水20克、甘油硬脂酸酯10克、没药提取物3克、互叶白千层叶油2克、薰衣草油2克、十八醇5克、香叶天竺葵提取物1克、蓝桉叶油2克、迷迭香油2克、生育酚1克、氢化霍霍巴油1克、牛至油1克、百里香油1克、雪柏油1克、香蜂草油1克、十二烷基硫酸钠1克、羟苯乙酯0.05克。
实施例2、
本实施例包括如下组成的各物质:水50克、甘油硬脂酸酯30克、没药提取物10克、互叶白千层叶油10克、薰衣草油10克、十八醇7克、香叶天竺葵提取物6克、蓝桉叶油5克、迷迭香油5克、生育酚3克、氢化霍霍巴油3克、牛至油3克、百里香油3克、雪柏油3克、香蜂草油3克、十二烷基硫酸钠1克、羟苯乙酯0.2克。
实施例3、
本实施例包括如下组成的各物质:水26克、甘油硬脂酸酯14克、没药提取物4克、互叶白千层叶油3克、薰衣草油3克、十八醇6克、香叶天竺葵提取物2克、蓝桉叶油3克、迷迭香油3克、生育酚2克、氢化霍霍巴油2克、牛至油2克、百里香油2克、雪柏油2克、香蜂草油2克、十二烷基硫酸钠1克、羟苯乙酯0.1克。
实施例4、
本实施例包括如下组成的各物质:水32克、甘油硬脂酸酯18克、没药提取物6克、互叶白千层叶油5克、薰衣草油5克、十八醇5克、香叶天竺葵提取物3克、蓝桉叶油4克、迷迭香油4克、生育酚1克、氢化霍霍巴油1克、牛至油1克、百里香油1克、雪柏油1克、香蜂草油1克、十二烷基硫酸钠1克、羟苯乙酯0.15克。
实施例5、
本实施例包括如下组成的各物质:水38克、甘油硬脂酸酯22克、没药提取物7克、互叶白千层叶油7克、薰衣草油7克、十八醇6克、香叶天竺葵提取物4克、蓝桉叶油3克、迷迭香油3克、生育酚2克、氢化霍霍巴油2克、牛至油2克、百里香油2克、雪柏油2克、香蜂草油2克、十二烷基硫酸钠1克、羟苯乙酯0.1克。
实施例6、
本实施例包括如下组成的各物质:水44克、甘油硬脂酸酯26克、没药提取物9克、互叶白千层叶油9克、薰衣草油9克、十八醇7克、香叶天竺葵提取物5克、蓝桉叶油4克、迷迭香油4克、生育酚3克、氢化霍霍巴油3克、牛至油3克、百里香油3克、雪柏油3克、香蜂草油3克、十二烷基硫酸钠1克、羟苯乙酯0.15克。
此产品属于膏体状态,罐装于软管内,携带方便,可涂擦于需调理修护处,每天两至三次,效果显著。
为了证明本发明的有益效果,对各实施例制备的皮肤(尤其是足部皮肤修护)调理膏进行了性能测试,具体试验情况如下:
1、抗敏、止痒测试
按实施例1-3的组分配比,使用本发明所公开的制备方法制备皮肤调理膏,将该皮肤调理膏用于临床实验,临床实验对象为:有轻微脚气症状,如:红斑、瘙痒症状志愿者90名,不分男女,脚上症状点不止一处的人群。
将90名志愿者随机分成3组,每组30个人,脚上一半的症状点使用产品,每天2-3次,连续使用一周;另一半的症状点不使用产品。3组志愿者使用的产品分别为按实施例1、实施例2、实施例3的配比制备的产品。实验结果如下表1-3所示:
表1按实施例1配比制备的产品使用效果
表2按实施例2配比制备的产品使用效果
表3按实施例3配比制备的产品使用效果
此实验为自身对照组,使用产品的症状部位,大部分使用者在10分钟到60分钟之间症状就会有所改善,瘙痒症状缓解;连续使用一周后,使用产品的症状部位红斑、瘙痒全部消失。而不使用产品症状部位,大部分使用者红斑、瘙痒不会自然消失,会一直延续症状,部分使用者会因为抓挠原因,甚至出现破皮或溃烂现象。
通过此测试说明本产品对脚气过敏症状:红斑、瘙痒症状,效果明显。
2、对足部水泡和溃烂、出水症状效果测试
按实施例4-6的组分配比,使用本发明所公开的制备方法制备皮肤调理膏,将该皮肤调理膏用于临床实验,临床实验对象为:有比较严重脚气症状,如:水泡、溃烂症状志愿者90名,不分男女,脚上症状点不止一处的人群。
将90名志愿者随机分成3组,每组30个人,脚上一半的症状点使用产品,每天2-3次,连续使用一周;另一半的症状点不使用产品。3组志愿者使用的产品分别为按实施例4、实施例5、实施例6的配比制备的产品。实验结果如下表4-6所示:
表4按实施例4配比制备的产品使用效果
表5按实施例5配比制备的产品使用效果
表6按实施例6配比制备的产品使用效果
此实验为自身对照组,使用产品的症状部位,大部分使用者24小时内开始有较为明显效果,一天之后,水泡开始减轻,出水状态开始减少,溃烂部位开始修复。连续使用一周后,水泡消失,不严重的溃烂部位已经修复,严重的溃烂部位已经结痂。而对比不使用产品症状部位,部分人群水泡会自然消失,但周期很长会持续2周到一个月,部分人群水泡会更严重到破裂并出水以至溃烂;已经溃烂部位很难短时间内自然恢复。
通过此测试说明本产品对足部水泡和溃烂、出水症状效果明显。
上述实施方式并非是对本发明的限制,本发明也并不仅限于上述举例,本技术领域的技术人员在本发明的技术方案范围内所做出的变化、改型、添加或替换,也均属于本发明的保护范围。
Claims (5)
1.一种皮肤调理膏,其特征在于:所述调理膏由以下质量份的各物质制成:
水20-50克、甘油硬脂酸酯10-30克、没药提取物3-10克、互叶白千层叶油2-10克、薰衣草油2-10克、十八醇5-7克、香叶天竺葵提取物1-6克、蓝桉叶油2-5克、迷迭香油2-5克、生育酚1-3克、氢化霍霍巴油1-3克、牛至油1-3克、百里香油1-3克、雪柏油1-3克、香蜂草油1-3克、十二烷基硫酸钠1克、羟苯乙酯0.05-0.2克。
2.根据权利要求1所述的皮肤调理膏及方法,其特征在于:所述调理膏由以下质量份的各物质制成:
水20克、甘油硬脂酸酯10克、没药提取物3克、互叶白千层叶油2克、薰衣草油2克、十八醇5克、香叶天竺葵提取物1克、蓝桉叶油2克、迷迭香油2克、生育酚1克、氢化霍霍巴油1克、牛至油1克、百里香油1克、雪柏油1克、香蜂草油1克、十二烷基硫酸钠1克、羟苯乙酯0.05克。
3.根据权利要求1所述的皮肤调理膏及方法,其特征在于:所述调理膏由以下质量份的各物质制成:
水50克、甘油硬脂酸酯30克、没药提取物10克、互叶白千层叶油10克、薰衣草油10克、十八醇7克、香叶天竺葵提取物6克、蓝桉叶油5克、迷迭香油5克、生育酚3克、氢化霍霍巴油3克、牛至油3克、百里香油3克、雪柏油3克、香蜂草油3克、十二烷基硫酸钠1克、羟苯乙酯0.2克。
4.一种如权利要求1所述的皮肤调理膏的方法,其特征在于:所述制备方法包括以下步骤:
分别称取甘油硬脂酸酯10-30克、没药提取物3-10克、互叶白千层叶油2-10克、薰衣草油2-10克、十八醇5-7克、蓝桉叶油2-5克、迷迭香油2-5克、生育酚1-3克、氢化霍霍巴油1-3克,形成第一组分;
分别称取水20-50克、十二烷基硫酸钠1克、羟苯乙酯0.05-0.2克混合均匀,形成第二组分;
称取香叶天竺葵提取物1-6克,牛至油1-3克,百里香油1-3克,雪柏油1-3克,香蜂草油1-3克,形成第三组分;
将第一组分和第二组分分别加热至80摄氏度,然后将第二组分加入至第一组分中,不断搅拌,在冷却至30摄氏度时加入第三组分,充分搅拌,完成制备;制备好的成品在分装之前需要放置于干燥、阴凉不见光环境。
5.根据权利要求4所述的皮肤调理膏的方法,其特征在于:所述没药提取物、互叶白千层叶油、薰衣草油、香叶天竺葵提取物、蓝桉叶油、迷迭香油、牛至油、百里香油、雪柏油、香蜂草油是分别以新鲜或干燥的没药、互叶白千层叶、薰衣草、香叶天竺葵、蓝桉叶、迷迭香花叶、牛至叶、百里香花叶、雪柏枝叶、香蜂草枝叶为原料,然后分别经以下工序制作而成:
粉碎:将各成分新鲜的或经过干燥的植物材料分别进行粉碎处理;
蒸馏:将经粉粹处理的材料分别放进蒸气热熔炉中,由下方加热送入蒸气,把植物中的挥发性精油蒸发出来,使之变成含有精油的水蒸气状态;
冷凝:再通过急冻箱的导管收集冷却后,水蒸气因冷却而凝结成液态,冷凝后精油浮于液面;
提取:再比较水与精油的密度将浮于液面的精油分离出来,得到调配皮肤修护精华油的各种成品原料。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011051207.3A CN112168726A (zh) | 2020-09-29 | 2020-09-29 | 一种皮肤调理膏及方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011051207.3A CN112168726A (zh) | 2020-09-29 | 2020-09-29 | 一种皮肤调理膏及方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112168726A true CN112168726A (zh) | 2021-01-05 |
Family
ID=73946966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011051207.3A Pending CN112168726A (zh) | 2020-09-29 | 2020-09-29 | 一种皮肤调理膏及方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112168726A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112842970A (zh) * | 2021-03-29 | 2021-05-28 | 重庆文理学院 | 一种儿童润肤乳及其制备方法与应用 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010001665A1 (en) * | 1999-02-11 | 2001-05-24 | Marie Harbeck | Cream compositions for skin management |
| US20010005509A1 (en) * | 1999-02-11 | 2001-06-28 | Marie Harbeck | Foot cream composition |
| CN109248194A (zh) * | 2018-11-13 | 2019-01-22 | 安徽丰乐香料有限责任公司 | 一种治疗脚气的精油组合物及其制剂 |
| CN110859872A (zh) * | 2019-12-04 | 2020-03-06 | 湖北创界生物科技有限公司 | 一种消炎杀菌的精油组合物、其制备方法及应用 |
-
2020
- 2020-09-29 CN CN202011051207.3A patent/CN112168726A/zh active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20010001665A1 (en) * | 1999-02-11 | 2001-05-24 | Marie Harbeck | Cream compositions for skin management |
| US20010005509A1 (en) * | 1999-02-11 | 2001-06-28 | Marie Harbeck | Foot cream composition |
| CN109248194A (zh) * | 2018-11-13 | 2019-01-22 | 安徽丰乐香料有限责任公司 | 一种治疗脚气的精油组合物及其制剂 |
| CN110859872A (zh) * | 2019-12-04 | 2020-03-06 | 湖北创界生物科技有限公司 | 一种消炎杀菌的精油组合物、其制备方法及应用 |
Non-Patent Citations (1)
| Title |
|---|
| 广州弘莉生物科技有限公司: "渡足清芳修护精华油", 《国产非特殊用途化妆品备案服务平台》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN112842970A (zh) * | 2021-03-29 | 2021-05-28 | 重庆文理学院 | 一种儿童润肤乳及其制备方法与应用 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106880551B (zh) | 一种紧致滋润柔滑肌肤的身体乳及其制备方法 | |
| CN102342993B (zh) | 一种皮肤抗敏修复外用制剂 | |
| CN112870116B (zh) | 滋润保湿修复嘴唇的润唇膏及其制备方法、滋润保湿修复嘴唇的口红及其制备方法 | |
| CN106473996B (zh) | 一种控油焕肤祛痘修复洗面奶及其制备方法 | |
| CN111388358A (zh) | 一种具有杀螨祛痘功效的植物精油组合物及制备和应用 | |
| CN107157853A (zh) | 一种植物型保湿防冻裂护手霜 | |
| CN113018238A (zh) | 一种抑菌消炎清爽益肤的祛痘凝胶及其制备方法 | |
| CN112006958A (zh) | 脱毛膏及制备方法 | |
| CN103989601A (zh) | 一种焕颜保湿嫩肤面霜及其制备方法 | |
| CN115025009A (zh) | 多功能曼尼古根冰河泥太空沙状清洁泥膜及其制备方法 | |
| KR102217697B1 (ko) | 천연 아로마 오일을 포함하는 아로마테라피용 조성물 | |
| CN107213095A (zh) | 一种控油净痘修护乳 | |
| CN105267119B (zh) | 一种滋养保湿与损伤修复润唇膏及其制备方法 | |
| CN112842943A (zh) | 一种止痒保湿修护肌肤的乳霜及其制备方法 | |
| CN106333909B (zh) | 一种淡化面部红血丝修复肌肤的乳液及其制备方法 | |
| CN114099387B (zh) | 一种玫瑰美白保湿精华乳及其制备方法 | |
| CN116350528A (zh) | 一种沸石温感清洁泥膜及其制备方法与使用方法 | |
| CN112168726A (zh) | 一种皮肤调理膏及方法 | |
| CN113679640A (zh) | 一种天然滋养净肤护肤祛痘洁面凝露及其制备方法 | |
| CN113278477A (zh) | 一种美白保湿滋润抑菌的沐浴皂及其制备方法 | |
| US20190160134A1 (en) | Formulations for Cosmetic and Dermatological Applications | |
| CN103565693B (zh) | 一种滋润护肤乳液及其制备方法 | |
| CN107496286A (zh) | 一种淡化细纹补水滋润型水乳及其制备方法 | |
| CN107260622B (zh) | 一种生肌敛口滋润保湿防裂膏及其制备方法 | |
| CN118178265A (zh) | 一种玫瑰香体保健膏及其制备工艺、应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210105 |